Bacteromic

Bacteromic Sp. z o.o. is a part of the Scope Fluidics Group and was established to develop the BACTEROMIC system, used to assess the drug susceptibility of microorganisms. The BACTEROMIC system enables phenotypic evaluation of the efficacy of antibiotics, used to treat infections of the respiratory system, blood, urinary tract, skin, and other areas. It also has the capability to detect resistance mechanisms. Thanks to the determination and expertise of a multidisciplinary team of biotechnologists, engineers and software developers, and their innovative approach to modern diagnostics, this device holds significant market potential and the ability to revolutionize antibiotic treatment.